// App-Quantinova.ai

3480 : Immunomodulatory Interventions Based on Minimal Residual Disease before and after Transplantation for Childhood Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Adriana Balduzzi

Principal Investigators

  • Lucia Di Maio

  • Daniela Silvestri

  • Simona Songia

  • Giulia Prunotto

  • Sonia Bonanomi

  • Attilio Rovelli

  • Andrea Biondi

  • Giovanni Cazzaniga

  • Maria Grazia Valsecchi

Medical Centers

  • Centro Ricerca Tettamanti, Universit degli Studi di Milano-Bicocca, Monza, Italy

  • Clinica Pediatrica, Universit degli studi di Milano-Bicocca, Fondazione MBBM/Ospedale S. Gerardo, Monza, Italy

  • Universit degli Studi di Milano-Bicocca, Centro Ricerca Tettamanti, Clinica Pediatrica, Monza, Italy

  • Universit degli Studi di Milano-Bicocca, Centro di Ricerca in Biostatistica per -Epidemiologia Clinica, Dipartimento di Scienze della Salute, Monza, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved